2 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
Follow LN-145: new trials by email Literature Review of LN-145 trials Research Report on LN-145
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors Lifileucel, LN-145, Pembrolizumab - Metastatic Melanoma, Squamous Cell Carcinoma of the Head and Neck | Phase 2 | Terminated | Iovance Biotherapeutics, Inc. | 225 | 2019-05-07 | 2026-05-15 |
| Study of LN-145, Autologous Tumor Infiltrating Lymphocytes in the Treatment of Patients With Cervical Carcinoma LN-145, LN-145 + pembrolizumab - Cervical Carcinoma | Phase 2 | Terminated | Iovance Biotherapeutics, Inc. | 210 | 2017-06-22 | 2026-09-25 |
Carcinoma, Non-Small-Cell Lung (1) · Melanoma (1) · Squamous Cell Carcinoma of Head and Neck (1) · Uterine Cervical Neoplasms (1)
Iovance Biotherapeutics, Inc. (2)
Germany (2) · Spain (2) · Switzerland (2) · United Kingdom (2) · United States (2) · Canada (1) · France (1) · Greece (1) · Italy (1) · Netherlands (1)
2018 (1)